A Bangladeshi pharma company will soon release a generic version of an expensive drug for cystic fibrosis that will allow hundreds of patients worldwide to access treatment. The only pharmaceutical option available for cystic fibrosis has for years been a combination treatment called ETI (elexacaftor/tezacaftor/ivacaftor) priced between $300,000 and $370,000. Drug discovery, testing, and complying […] The post Expensive Cystic Fibrosis Drug Now Within Reach After Dramatic Price Drop of New Generic Version appeared first on Good News Network.